Edwards Lifesciences (EW) Tops Q3 EPS by 5c, Offers Q4 Guidance
Tweet
Share
E-mail
Get Alerts EW Hot Sheet
Price: $85.11 -0.76%
Revenue Growth %: +11.1%
Financial Fact:
Provision for income taxes: 43.8M
Today's EPS Names:
PLCE, COE, JVA, More
Revenue Growth %: +11.1%
Financial Fact:
Provision for income taxes: 43.8M
Today's EPS Names:
PLCE, COE, JVA, More
Join SI Premium – FREE
Edwards Lifesciences (NYSE: EW) reported Q3 EPS of $1.07, $0.05 better than the analyst estimate of $1.02. Revenue for the quarter came in at $907 million versus the consensus estimate of $928.18 million.
GUIDANCE:
Edwards Lifesciences sees Q4 2018 EPS of $1.05-$1.20, versus the consensus of $1.21. Edwards Lifesciences sees Q4 2018 revenue of $950-1000 million, versus the consensus of $995.4 million.
For earnings history and earnings-related data on Edwards Lifesciences (EW) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- MIND Technology (MIND) Misses Q1 EPS by 5c
- Oracle (ORCL) Tops Q4 EPS by 16c, Offers Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
